Time Savings Gained in Retrospective Study of Glioma
Glioma: MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study...
Glioma: MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study...
Glioblastoma: MERIT was engaged mid-study to supply the high-quality imaging data and expertise needed to keep a Phase II glioblastoma study on track. Learn how this resulted in a significant cost savings for the Sponsor...
Retinopathy of Prematurity (ROP): Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP. ...
AI: High-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Gene Therapy: MERIT’s imaging expertise and proprietary software played a vital role in gene therapy clinical trials....
Wet AMD: Our imaging expertise and proprietary software performed a crucial role in this global phase III wet AMD Study....
Asthma: MERIT’s spirometry and MBPC expertise supported FDA approval for generic albuterol....
COPD: Serial spirometry for multi-study drug development program led to FDA approval of new treatment. ...